A after-weekly injectable medication that works likewise to the opposite drugs during the GLP-1 family, but is also an agonist for a 2nd peptide hormone identified as GIP. It's indicated with the treatment of overweight and obesity. Tirzepatide can be simpler than semaglutide in assisting peo